Page last updated: 2024-08-25

atovaquone and Acquired Immune Deficiency Syndrome

atovaquone has been researched along with Acquired Immune Deficiency Syndrome in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	18 (81.82)	18.2507
2000's	3 (13.64)	29.6817
2010's	1 (4.55)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asagiri, T; Nakamura, M; Okazaki, M; Takeuchi, S	1
Robbins, GK; Telford, SR; Vyas, JM	1
Chouette, I; Lafeuillade, A; Navarreté, MS; Pellegrino, P; Poggi, C; Profizi, N; Quilichini, R	1
Hansson, AG; Jatlow, P; Mitchell, S; Rainey, PM	1
Anwar-Bruni, DM; Bryan, RT; Hogan, SE; Lennox, JL; Schwartz, DA; Wilcox, CM	1
Gourdon, D; Katlama, C; Lapierre, D; Mouthon, B; Rousseau, F	1
Brettle, RP; Burns, SM; Flegg, PJ; Laing, RB; Leen, CL	1
McKendrick, MW; Nash, C; Vilar, FJ	1
Cirioni, O; Giacometti, A; Scalise, G	1
Burchett, S; Dankner, WM; Hughes, WT; Ngo, LY; Sadler, B; Unadkat, JD; Xu, J; Yogev, R	1
Armstrong, W; Beard, CB; Burman, W; Carter, J; Crane, L; Duchin, J; Hossler, PA; Huang, L; Kazanjian, P; Lee, CH; Meshnick, SR; Richardson, J	1
Andersen, J; Bosler, EM; Chirgwin, K; Hafner, R; Jayaweera, DT; Leport, C; Luft, BJ; McAuliffe, V; Morlat, P; Rajicic, N; Remington, J; Roque, C; Vilde, JL	1
Kovacs, JA	1
de Smet, MD; Lopez, JS; Masur, H; Mueller, BU; Nussenblatt, RB; Pizzo, PA	1
Dickins, M; Ginger, CD; Gutteridge, WE; Holdich, T; Hudson, AT; Hutchinson, DB; Latter, VS; Pudney, M; Randall, AW	1
Davey, RT; Falloon, J; Feuerstein, I; Hughes, W; Kovacs, J; LaFon, S; Lancaster, D; O'Neill, D; Polis, M; Rogers, M	1
Araujo, FG; Huskinson, J; Remington, JS	1

Trials

5 trial(s) available for atovaquone and Acquired Immune Deficiency Syndrome

Article	Year
Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. AIDS (London, England), 1996, Volume: 10, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Atovaquone; Clindamycin; Encephalitis; Female; Humans; Male; Naphthoquinones; Pyrimethamine; Recurrence; Risk Factors; Sulfadiazine; Survival Analysis; Time Factors; Toxoplasmosis, Cerebral	1996
Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 Team. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-Bacterial Agents; Antifungal Agents; Atovaquone; Azithromycin; Child; Child, Preschool; Cross-Over Studies; Drug Interactions; HIV-1; Humans; Naphthoquinones	1999
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, May-01, Volume: 34, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Atovaquone; Drug Therapy, Combination; Encephalitis; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Pyrimethamine; Sulfadiazine; Time Factors; Toxoplasma; Treatment Outcome	2002
Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program. Lancet (London, England), 1992, Sep-12, Volume: 340, Issue:8820 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Anti-Infective Agents; Atovaquone; Biopsy; Enzyme-Linked Immunosorbent Assay; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naphthoquinones; Recurrence; Toxoplasmosis, Cerebral	1992
A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. The New England journal of medicine, 1991, Nov-28, Volume: 325, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Atovaquone; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Partial Pressure; Pneumonia, Pneumocystis; Recurrence; Treatment Outcome	1991

Other Studies

17 other study(ies) available for atovaquone and Acquired Immune Deficiency Syndrome

Article	Year
Consecutive hypoglycemia attacks induced by co-trimoxazole followed by pentamidine in a patient with acquired immunodeficiency syndrome. International journal of STD & AIDS, 2019, Volume: 30, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Aged; Anti-Infective Agents; Atovaquone; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoglycemia; Pentamidine; Pneumonia, Pneumocystis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2019
Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Dec-15, Volume: 45, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Animals; Atovaquone; Babesia microti; Babesiosis; Drug Combinations; Humans; Immunocompromised Host; Male; Middle Aged; Proguanil	2007
Drugs for AIDS and associated infections. The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine	1995
[Efficacy of atovaquone in resistant toxoplasmosis in AIDS]. Presse medicale (Paris, France : 1983), 1993, Oct-30, Volume: 22, Issue:33 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Drug Resistance, Microbial; Humans; Naphthoquinones; Toxoplasmosis, Cerebral	1993
Rapid high-performance liquid chromatographic assay for atovaquone. Journal of chromatography. B, Biomedical applications, 1996, Jan-12, Volume: 675, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Atovaquone; Chromatography, High Pressure Liquid; Naphthoquinones; Pneumonia, Pneumocystis; Reproducibility of Results; Spectrophotometry, Ultraviolet	1996
Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1-infected patients. AIDS (London, England), 1996, Volume: 10, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Atovaquone; Cohort Studies; HIV-1; Humans; Intestines; Male; Microsporida; Naphthoquinones; Protozoan Infections; Retrospective Studies	1996
Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. International journal of STD & AIDS, 1996, Volume: 7, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atovaquone; Autopsy; Azithromycin; Brain; CD4 Lymphocyte Count; Clindamycin; Drug Therapy, Combination; Female; Humans; Incidence; Lymphoma, AIDS-Related; Male; Middle Aged; Naphthoquinones; Pyrimethamine; Retrospective Studies; Sulfadiazine; Toxoplasmosis, Cerebral; United Kingdom	1996
Atovaquone as prophylaxis for Pneumocystis carinii. International journal of STD & AIDS, 1996, Volume: 7, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; CD4 Lymphocyte Count; Female; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1996
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Artemisinins; Atovaquone; Cryptosporidiosis; Cryptosporidium parvum; Dapsone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lactones; Macrolides; Minocycline; Naphthoquinones; Pyrimethamine; Sesquiterpenes	1996
Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. The Journal of infectious diseases, 2001, Mar-01, Volume: 183, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Atovaquone; Case-Control Studies; Cohort Studies; Cytochrome b Group; Female; Gene Amplification; Humans; Male; Middle Aged; Molecular Sequence Data; Naphthoquinones; Pneumocystis; Pneumonia, Pneumocystis; Polymerase Chain Reaction; Polymorphism, Genetic; Retrospective Studies; Survival; Treatment Outcome; Ubiquinone	2001
New AIDS drug available. AORN journal, 1992, Volume: 55, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Atovaquone; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1992
Orally administered 566C80 for treatment of ocular toxoplasmosis in a patient with the acquired immunodeficiency syndrome. American journal of ophthalmology, 1992, Mar-15, Volume: 113, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Antiprotozoal Agents; Atovaquone; Eye Infections, Parasitic; Follow-Up Studies; Fundus Oculi; Humans; Male; Naphthoquinones; Toxoplasmosis, Ocular	1992
Treatment IND protocol announced for Pneumocystis carinii pneumonia. Clinical pharmacy, 1992, Volume: 11, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Atovaquone; Clinical Protocols; Drugs, Investigational; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1992
AIDS-related treatment receives IND status. The Journal of the American Osteopathic Association, 1992, Volume: 92, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Atovaquone; Drugs, Investigational; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1992
566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs under experimental and clinical research, 1991, Volume: 17, Issue:9 Topics: 4-Quinolones; Acquired Immunodeficiency Syndrome; Adult; Animals; Anti-Infective Agents; Antimalarials; Aotus trivirgatus; Atovaquone; Dogs; Humans; Malaria, Falciparum; Male; Microsomes, Liver; Middle Aged; NADP; Naphthoquinones; Opportunistic Infections; Plasmodium; Rats; Toxoplasma	1991
FDA authorizes wider use of new oral medication for AIDS. Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Atovaquone; Drugs, Investigational; Humans; Naphthoquinones; Pneumonia, Pneumocystis	1991
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Infective Agents; Atovaquone; Brain; Cell Division; Female; Humans; Mice; Mice, Inbred CBA; Naphthoquinones; Toxoplasma; Toxoplasmosis; Uracil	1991